vs
Side-by-side financial comparison of Agilent Technologies (A) and Synopsys (SNPS). Click either name above to swap in a different company.
Synopsys is the larger business by last-quarter revenue ($2.3B vs $1.8B, roughly 1.3× Agilent Technologies). Synopsys runs the higher net margin — 19.9% vs 17.0%, a 2.9% gap on every dollar of revenue. On growth, Synopsys posted the faster year-over-year revenue change (50.6% vs 7.0%). Synopsys produced more free cash flow last quarter ($605.2M vs $175.0M). Over the past eight quarters, Synopsys's revenue compounded faster (16.9% CAGR vs 6.9%).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
Synopsys, Inc. is an American multinational electronic design automation (EDA) company headquartered in Sunnyvale, California, that focuses on design and verification of silicon chips, electronic system-level design and verification, and reusable components. Synopsys supplies tools and services to the semiconductor design and manufacturing industry.
A vs SNPS — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $2.3B |
| Net Profit | $305.0M | $448.7M |
| Gross Margin | 52.6% | 71.0% |
| Operating Margin | 19.6% | 5.4% |
| Net Margin | 17.0% | 19.9% |
| Revenue YoY | 7.0% | 50.6% |
| Net Profit YoY | -4.1% | -59.7% |
| EPS (diluted) | $1.07 | $2.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.9B | $2.3B | ||
| Q3 25 | $1.7B | $1.7B | ||
| Q2 25 | $1.7B | $1.6B | ||
| Q1 25 | $1.7B | $1.5B | ||
| Q4 24 | $1.7B | $1.5B | ||
| Q3 24 | $1.6B | $1.5B | ||
| Q2 24 | $1.6B | $1.5B |
| Q1 26 | $305.0M | — | ||
| Q4 25 | $434.0M | $448.7M | ||
| Q3 25 | $336.0M | $242.5M | ||
| Q2 25 | $215.0M | $345.3M | ||
| Q1 25 | $318.0M | $295.7M | ||
| Q4 24 | $351.0M | $1.1B | ||
| Q3 24 | $282.0M | $408.1M | ||
| Q2 24 | $308.0M | $292.1M |
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | 71.0% | ||
| Q3 25 | 51.1% | 78.1% | ||
| Q2 25 | 51.9% | 80.2% | ||
| Q1 25 | 53.5% | 81.4% | ||
| Q4 24 | 53.9% | 78.3% | ||
| Q3 24 | 54.2% | 80.9% | ||
| Q2 24 | 54.4% | 79.4% |
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | 5.4% | ||
| Q3 25 | 20.7% | 9.5% | ||
| Q2 25 | 18.0% | 23.5% | ||
| Q1 25 | 22.4% | 17.3% | ||
| Q4 24 | 24.0% | 20.3% | ||
| Q3 24 | 21.1% | 23.6% | ||
| Q2 24 | 23.1% | 22.8% |
| Q1 26 | 17.0% | — | ||
| Q4 25 | 23.3% | 19.9% | ||
| Q3 25 | 19.3% | 13.9% | ||
| Q2 25 | 12.9% | 21.5% | ||
| Q1 25 | 18.9% | 20.3% | ||
| Q4 24 | 20.6% | 74.4% | ||
| Q3 24 | 17.9% | 26.7% | ||
| Q2 24 | 19.6% | 20.1% |
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | $2.44 | ||
| Q3 25 | $1.18 | $1.50 | ||
| Q2 25 | $0.75 | $2.21 | ||
| Q1 25 | $1.11 | $1.89 | ||
| Q4 24 | $1.23 | $7.13 | ||
| Q3 24 | $0.97 | $2.61 | ||
| Q2 24 | $1.05 | $1.88 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | $3.0B |
| Total DebtLower is stronger | $3.0B | $13.5B |
| Stockholders' EquityBook value | $6.9B | $28.3B |
| Total Assets | $12.8B | $48.2B |
| Debt / EquityLower = less leverage | 0.44× | 0.48× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | $3.0B | ||
| Q3 25 | $1.5B | $2.6B | ||
| Q2 25 | $1.5B | $14.3B | ||
| Q1 25 | $1.5B | $3.8B | ||
| Q4 24 | $1.3B | $4.1B | ||
| Q3 24 | $1.8B | $2.0B | ||
| Q2 24 | $1.7B | $1.7B |
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | $13.5B | ||
| Q3 25 | $3.4B | $14.3B | ||
| Q2 25 | $3.3B | $10.1B | ||
| Q1 25 | $3.3B | — | ||
| Q4 24 | $3.3B | — | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.1B | — |
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.7B | $28.3B | ||
| Q3 25 | $6.4B | $27.6B | ||
| Q2 25 | $6.1B | $9.9B | ||
| Q1 25 | $6.0B | $9.3B | ||
| Q4 24 | $5.9B | $9.0B | ||
| Q3 24 | $5.9B | $7.7B | ||
| Q2 24 | $6.2B | $7.2B |
| Q1 26 | $12.8B | — | ||
| Q4 25 | $12.7B | $48.2B | ||
| Q3 25 | $12.2B | $48.2B | ||
| Q2 25 | $12.2B | $23.8B | ||
| Q1 25 | $11.9B | $13.0B | ||
| Q4 24 | $11.8B | $13.1B | ||
| Q3 24 | $11.0B | $11.6B | ||
| Q2 24 | $10.9B | $11.0B |
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | 0.48× | ||
| Q3 25 | 0.53× | 0.52× | ||
| Q2 25 | 0.55× | 1.01× | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 0.57× | — | ||
| Q3 24 | 0.36× | — | ||
| Q2 24 | 0.34× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $268.0M | $639.7M |
| Free Cash FlowOCF − Capex | $175.0M | $605.2M |
| FCF MarginFCF / Revenue | 9.7% | 26.8% |
| Capex IntensityCapex / Revenue | 5.2% | 1.5% |
| Cash ConversionOCF / Net Profit | 0.88× | 1.43× |
| TTM Free Cash FlowTrailing 4 quarters | $993.0M | $1.3B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $639.7M | ||
| Q3 25 | $362.0M | $671.0M | ||
| Q2 25 | $221.0M | $275.4M | ||
| Q1 25 | $431.0M | $-67.5M | ||
| Q4 24 | $481.0M | $562.8M | ||
| Q3 24 | $452.0M | $455.4M | ||
| Q2 24 | $333.0M | $476.6M |
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $605.2M | ||
| Q3 25 | $259.0M | $632.4M | ||
| Q2 25 | $107.0M | $219.8M | ||
| Q1 25 | $334.0M | $-108.2M | ||
| Q4 24 | $388.0M | $558.4M | ||
| Q3 24 | $360.0M | $415.4M | ||
| Q2 24 | $230.0M | $438.2M |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | 26.8% | ||
| Q3 25 | 14.9% | 36.3% | ||
| Q2 25 | 6.4% | 13.7% | ||
| Q1 25 | 19.9% | -7.4% | ||
| Q4 24 | 22.8% | 37.3% | ||
| Q3 24 | 22.8% | 27.2% | ||
| Q2 24 | 14.6% | 30.1% |
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | 1.5% | ||
| Q3 25 | 5.9% | 2.2% | ||
| Q2 25 | 6.8% | 3.5% | ||
| Q1 25 | 5.8% | 2.8% | ||
| Q4 24 | 5.5% | 0.3% | ||
| Q3 24 | 5.8% | 2.6% | ||
| Q2 24 | 6.5% | 2.6% |
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | 1.43× | ||
| Q3 25 | 1.08× | 2.77× | ||
| Q2 25 | 1.03× | 0.80× | ||
| Q1 25 | 1.36× | -0.23× | ||
| Q4 24 | 1.37× | 0.51× | ||
| Q3 24 | 1.60× | 1.12× | ||
| Q2 24 | 1.08× | 1.63× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
SNPS
| License And Maintenance | $940.7M | 42% |
| Other | $640.0M | 28% |
| Design IP Segment | $407.1M | 18% |
| KR | $236.9M | 11% |
| Sales Based Royalties | $30.1M | 1% |
